Synergy CHC Expands FOCUSfactor Product Line in Canada

Written by Emily J. Thompson, Senior Investment Analyst

SNYR+3.82%

WMT-0.6%

MCK+0.91%

Updated: 13h ago

0mins

Synergy CHC (SNYR) announced a major expansion of its FOCUSfactor functional beverage portfolio across Canada, building on the successful launch of FOCUSfactor's supplement SKUs at Walmart (WMT) Canada and through McKesson (MCK) Canada during Q4 2025, with sell-through and consumer feedback supporting category expansion. "This is a major milestone for FOCUSfactor as we extend our cognitive performance platform deeper into the Canadian market," said Jack Ross, CEO of Synergy CHC Corp. "Walmart Canada's expanded assortment and McKesson's national authorization further validate consumer demand for functional beverages that deliver clean energy, focus and mental clarity without the crash associated with traditional energy drinks."

SNYR

$2.04+Infinity%1D

Analyst Views on SNYR

Wall Street analysts forecast SNYR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNYR is 7.00 USD with a low forecast of 7.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Analyst Rating

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 1.965

Low

7.00

Averages

7.00

High

7.00

Current: 1.965

Low

7.00

Averages

7.00

High

7.00

Roth Capital

Sean McGowan

Buy

downgrade

$10 -> $7

2025-11-14

Reason

Roth Capital

Sean McGowan

Price Target

$10 -> $7

AI Analysis

2025-11-14

downgrade

Buy

Reason

Roth Capital analyst Sean McGowan lowered the firm's price target on Synergy CHC to $7 from $10 and keeps a Buy rating on the shares. The company made good progress during Q3, broadening its distribution footprint for both supplements and beverages and continuing to expand geographically, though its results came up short of expectations due in part to cash being tight prior to the company's recent equity raise, the analyst tells investors in a research note. Roth adds however that Synergy now has the capital needed to post significant growth in 2026.

About SNYR

Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.